Co-Authors
This is a "connection" page, showing publications co-authored by Jorge Carrillo and Julià Blanco.
Connection Strength
4.357
-
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem Biophys Res Commun. 2021 01 29; 538:187-191.
Score: 0.912
-
Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Front Immunol. 2018; 9:2429.
Score: 0.792
-
Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan 14; 32(2):149-160.
Score: 0.750
-
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
Score: 0.238
-
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021 Mar 12; 2(3):313-320.e4.
Score: 0.232
-
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
Score: 0.232
-
Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults. Front Immunol. 2017; 8:1925.
Score: 0.187
-
Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. Front Immunol. 2017; 8:1154.
Score: 0.183
-
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif. Sci Rep. 2017 01 13; 7:40800.
Score: 0.175
-
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021 Dec; 10(1):797-809.
Score: 0.061
-
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report. Open Forum Infect Dis. 2021 Jul; 8(7):ofab329.
Score: 0.060
-
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen. Front Pharmacol. 2021; 12:646676.
Score: 0.059
-
SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus. Membranes (Basel). 2021 Jan 18; 11(1).
Score: 0.058
-
Pigs are not susceptible to SARS-CoV-2 infection but are a model for viral immunogenicity studies. Transbound Emerg Dis. 2021 Jul; 68(4):1721-1725.
Score: 0.057
-
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020 10 06; 117(40):24790-24793.
Score: 0.056
-
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
Score: 0.049
-
Interferon-?-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings. Clin Infect Dis. 2017 Oct 30; 65(10):1670-1675.
Score: 0.046
-
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B. PLoS One. 2017; 12(9):e0184929.
Score: 0.046
-
Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One. 2017; 12(9):e0184433.
Score: 0.046
-
IP-10 Levels as an Accurate Screening Tool to Detect Acute HIV Infection in Resource-Limited Settings. Sci Rep. 2017 08 14; 7(1):8104.
Score: 0.046
-
A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection. J Acquir Immune Defic Syndr. 2017 Apr 01; 74(4):459-466.
Score: 0.044
-
Host factors involved in low susceptibility to HIV infection. AIDS Rev. 2011 Jan-Mar; 13(1):30-40.
Score: 0.029